Teriparatide-denosumab combo shows promise for osteoporosis

05/15/2013 | HealthDay News

Combining teriparatide and denosumab was more effective than using the drugs alone in increasing bone density in postmenopausal women with osteoporosis, a small study found. The combination also was more effective than any drugs on the market today, the study author said. The findings appeared online in The Lancet.

View Full Article in:

HealthDay News

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Regulatory Counsel
Food and Drug Administration
Silver Spring, MD
Pharmacy Care Manager
National Association of Chain Drug Stores
Arlington, VA
Vice President, Commercial Markets
Meridian Health
Neptune, NJ
Health Plan CEO – Oregon
Trillium Community Health Plan
Eugene, OR
Director of Operations - GBS
Mayo Clinic
Rochester, MN